SEC Filing Details

SEC Filing Details

SEC Filing

Document Details

Form
8-K
Filing Date
Jan 5, 2024
Document Date
Jan 5, 2024
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Barinthus Biotherapeutics
Issuer
BARINTHUS BIOTHERAPEUTICS PLC.

Barinthus Biotherapeutics plc

Unit 6-10
Zeus Building
Rutherford Avenue
Harwell OX11 0DF
United Kingdom

T: +44 (0)1865 818808

Barinthus Biotherapeutics logo
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer.
© Barinthus Biotherapeutics 2024 All rights reserved.